NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Kemper AR, Coeytaux R, Sanders GD, et al. Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. (Comparative Effectiveness Reviews, No. 28.)
This publication is provided for historical reference only and the information may be out of date.
Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet].
Show detailsMara Becker, M.D., M.S.C.E.
University of Missouri/Kansas City
Kansas City, MO
Timothy Beukelman, M.D., M.S.C.E.
University of Alabama at Birmingham
Birmingham, AL
Gerald Gartlehner, M.D., M.P.H.
Danube University Krems;
Krems, Austria
Mark Hoeltzel, M.D.
Children's Mercy Hospital
Kansas City, MO
Norman T Ilowite, M.D.
Children's Hospital at Montefiore and Albert Einstein College of Medicine
Bronx, NY
Yuki Kimura, M.D.
Hackensack University Medical Center
Hackensack, NJ
Carole A Wallace, M.D.
University of Washington and Seattle
Children's Hospital
Seattle, WA
- Peer Reviewers - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With...Peer Reviewers - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA)
- Vertebral ArteryVertebral ArteryThe first branch of the SUBCLAVIAN ARTERY with distribution to muscles of the NECK; VERTEBRAE; SPINAL CORD; CEREBELLUM; and interior of the CEREBRUM.<br/>MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...